A new centralised hub aims to encourage use of health data and samples, but there are several hurdles to overcome

The first EU-funded research project into psychedelic drugs is a step on the way to legitimise the field and should lead to more funding

MEPs voted to adopt their negotiating position on the controversial reform, but it will not be finalised until after the European elections in June. Despite concessions, the pharma industry is not happy

Industry has welcomed the European Commission’s biotechnology and biomanufacturing initiative, but now wants to see some action

The new law is intended to allow EU citizens to access their health records when in any member state, and to choose whether or not to allow anonymized data to be shared for secondary use in research and public health

After long negotiations MEPs agreed on the EU’s pharmaceutical reform. It includes longer exclusivity for data filed to get marketing approval for new drugs. But pharma still isn’t happy

The creation of the European Health Data Space is in the balance, with talks between the Parliament and Council set to continue on Thursday, in a bid to agree a deal before the EU elections